Donor Viral Hepatitis and Liver Transplantation.
Hepatitis B
Hepatitis C
Liver
Transplantation
Journal
The Surgical clinics of North America
ISSN: 1558-3171
Titre abrégé: Surg Clin North Am
Pays: United States
ID NLM: 0074243
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
medline:
14
11
2023
pubmed:
13
11
2023
entrez:
12
11
2023
Statut:
ppublish
Résumé
Despite increasing numbers of organ transplants completed each year, there continues to be an organ shortage in liver transplantation. This has led to the utilization of previously discarded or "marginal" allografts, such as those from donors with hepatitis C virus (HCV) or hepatitis B virus (HBV). The advent of direct acting antivirals and nucleos(t)ide analogs has allowed these allografts to be safely transplanted regardless of the recipients' hepatitis status with comparable graft and patient survival. Recent advances have even allowed usage of actively viremic donors with similar graft and patient outcomes. This article presents an overview of the use of HCV positive and HBV positive allografts.
Identifiants
pubmed: 37953041
pii: S0039-6109(23)00112-3
doi: 10.1016/j.suc.2023.07.002
pii:
doi:
Substances chimiques
Antiviral Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
67-77Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.